SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Wednesday reported first-quarter profit of $32.1 million. On a per-share basis, the San ...
News
- Neurocrine: Q1 Earnings Snapshot
- Fate Therapeutics: Q1 Earnings Snapshot
The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share. The clinical-stage biotech company ...
- US backs waiving intellectual property rules on vaccines
Dr. Michelle McMurry-Heath, chief executive of the Biotechnology Innovation Organization trade group, said in a statement that the decision will ...
- The Use of Artificial Intelligence in Healthcare Accelerated During the Pandemic. It's Here to Stay.
... solutions for population-health management, directly benefiting providers, health plans, employers and pharmaceutical and biotech organizations.
- Peptide and Heparin Market to Reflect Impressive Growth Rate Along with Top Leading Players ...
Cipla Ltd., VHB Life Sciences Limited, Troikaa Pharmaceuticals Ltd., Emcure Pharmaceuticals Pvt. Ltd., Samarth Life Sciences ... 1604 W San Antonio,.